Literature DB >> 16041510

Hand preshaping in Parkinson's disease: effects of visual feedback and medication state.

Luis F Schettino1, Sergei V Adamovich, Wayne Hening, Eugene Tunik, Jacob Sage, Howard Poizner.   

Abstract

Previous studies in our laboratory examining pointing and reach-to-grasp movements of Parkinson's disease patients (PDPs) have found that PDPs exhibit specific deficits in movement coordination and in the sensorimotor transformations required to accurately guide movements. We have identified a particular difficulty in matching unseen limb position, sensed by proprioception, with a visible target. In the present work, we further explored aspects of complex sensorimotor transformation and motor coordination using a reach-to-grasp task in which object shape, visual feedback, and dopaminergic medication were varied. Normal performance in this task requires coordinated generation of appropriate reach, to bring the hand to the target, and differentiated grasp, to preshape the hand congruent with object form. In Experiment 1, we tested PDPs in the off-medication state. To examine the dependence of subjects on visual feedback and their ability to implement intermodal sensory integration, we required them to reach and grasp the target objects in three conditions: (1) Full Vision, (2) Object Vision with only the target object visible and, (3) No Vision with neither the moving arm nor the target object visible. PDPs exhibited two types of deficits. First, in all conditions, they demonstrated a generalized slowing of movement or bradykinesia. We consider this an intensive deficit, since it involves largely a modulation of the gain of specific task parameters: in this case, velocity of movement. Second, they were less able than controls to extract critical proprioceptive information and integrate it with vision in order to coordinate the reach and grasp components of movement. These deficits which involve the coordination of different inputs and motor components, we classify as coordinative deficits. As in our previous work, the PDPs' deficits were most marked when they were required to use proprioception to guide their hand to a visible target (Object Vision condition). But even in the full-vision condition, their performance only became fully accurate when both the target and effector (hand) were simultaneously visible. In Experiment 2, PDPs were tested on their dopaminergic replacement therapy. Dopaminergic treatment significantly ameliorated the bradykinesia of the PDPs, but produced no changes in the hand preshaping deficiencies of PDPs. These results suggest that adequate treatment of the PDPs may more readily compensate for intensive, than coordinative deficits, since the latter are likely to depend on specific and time-dependent neural interdependencies that are unlikely to be remediated simply by increasing the gain of a pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041510     DOI: 10.1007/s00221-005-0080-4

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  94 in total

1.  The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication.

Authors:  U Castiello; K M Bennett; C Bonfiglioli; R F Peppard
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

2.  Visual Information and Object Size in the Control of Reaching.

Authors:  N. E. Berthier; R. K. Clifton; V. Gullapalli; D. D. McCall; D. J. Robin
Journal:  J Mot Behav       Date:  1996-09       Impact factor: 1.328

3.  Grasp size and accuracy of approach in reaching.

Authors:  A M Wing; A Turton; C Fraser
Journal:  J Mot Behav       Date:  1986-09       Impact factor: 1.328

4.  Functional organization of inferior area 6 in the macaque monkey. II. Area F5 and the control of distal movements.

Authors:  G Rizzolatti; R Camarda; L Fogassi; M Gentilucci; G Luppino; M Matelli
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

5.  Simple and complex movements off and on treatment in patients with Parkinson's disease.

Authors:  R Benecke; J C Rothwell; J P Dick; B L Day; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

6.  Bradykinesia and impairment of EEG desynchronization in Parkinson's disease.

Authors:  P Brown; C D Marsden
Journal:  Mov Disord       Date:  1999-05       Impact factor: 10.338

7.  Adaptation of handwriting size under distorted visual feedback in patients with Parkinson's disease and elderly and young controls.

Authors:  H L Teulings; J L Contreras-Vidal; G E Stelmach; C H Adler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

8.  An evaluation of the role of internal cues in the pathogenesis of parkinsonian hypokinesia.

Authors:  N Georgiou; R Iansek; J L Bradshaw; J G Phillips; J B Mattingley; J A Bradshaw
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

9.  Human ballistic arm abduction movements: effects of L-dopa treatment in Parkinson's disease.

Authors:  A Baroni; F Benvenuti; L Fantini; T Pantaleo; F Urbani
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Disturbance of sequential movements in patients with Parkinson's disease.

Authors:  R Benecke; J C Rothwell; J P Dick; B L Day; C D Marsden
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

View more
  29 in total

1.  Robots integrated with virtual reality simulations for customized motor training in a person with upper extremity hemiparesis: a case study.

Authors:  Gerard G Fluet; Alma S Merians; Qinyin Qiu; Ian Lafond; Soha Saleh; Viviana Ruano; Andrea R Delmonico; Sergei V Adamovich
Journal:  J Neurol Phys Ther       Date:  2012-06       Impact factor: 3.649

2.  Role of vision in aperture closure control during reach-to-grasp movements.

Authors:  Miya K Rand; Martin Lemay; Linda M Squire; Yury P Shimansky; George E Stelmach
Journal:  Exp Brain Res       Date:  2007-05-03       Impact factor: 1.972

3.  Correlation among joint motions allows classification of Parkinsonian versus normal 3-D reaching.

Authors:  Jacky Chan; Howard Leung; Howard Poizner
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2009-06-02       Impact factor: 3.802

Review 4.  The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.

Authors:  Fabian J David; Miranda J Munoz; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2020-06-03       Impact factor: 1.972

5.  Scaling and coordination deficits during dynamic object manipulation in Parkinson's disease.

Authors:  Joseph Snider; Dongpyo Lee; Deborah L Harrington; Howard Poizner
Journal:  J Neurophysiol       Date:  2014-04-23       Impact factor: 2.714

6.  Bilateral deep brain stimulation of the subthalamic nucleus increases pointing error during memory-guided sequential reaching.

Authors:  Fabian J David; Lisa C Goelz; Ruth Z Tangonan; Leonard Verhagen Metman; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2018-02-09       Impact factor: 1.972

7.  Parkinson's disease patients show impaired corrective grasp control and eye-hand coupling when reaching to grasp virtual objects.

Authors:  J R Lukos; J Snider; M E Hernandez; E Tunik; S Hillyard; H Poizner
Journal:  Neuroscience       Date:  2013-09-19       Impact factor: 3.590

Review 8.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Control of aperture closure initiation during reach-to-grasp movements under manipulations of visual feedback and trunk involvement in Parkinson's disease.

Authors:  Miya Kato Rand; Martin Lemay; Linda M Squire; Yury P Shimansky; George E Stelmach
Journal:  Exp Brain Res       Date:  2009-11-10       Impact factor: 1.972

10.  Anticipatory modulation of digit placement for grasp control is affected by Parkinson's disease.

Authors:  Jamie R Lukos; Dongpyo Lee; Howard Poizner; Marco Santello
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.